Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Unity Health Toronto

$944,775.00

Deciphering the intracellular interactome of LDL during endothelial transcytosis - elucidating novel therapeutic targets for atherosclerosis

EF 2024-25

Résumé
Atherosclerosis leads to heart attacks and strokes and is a leading cause of death in Canada. The first step in the disease is the build-up of the bad cholesterol, LDL, in the wall of blood vessels. Specifically, LDL builds up under the innermost layer of arteries, called the endothelium. How the LDL gets under the endothelium is very poorly understood. We have discovered ways to study this process, which is known as LDL transcytosis. In earlier work, we discovered two molecules on the cell surface that bring LDL into the endothelial cell but almost nothing is known about what happens next. We now wish to understand the route taken by LDL as it traverses the cell. Does it interact with other parts of the cell? How does it move through the crowded cell? Understanding how LDL navigates across the endothelial cell will help us develop ways to prevent the development of heart disease. If we can prevent cholesterol from accumulating in the blood vessel wall, we will prevent heart disease and stroke. We will use sophisticated microscopes to study the process by which cholesterol builds up under the special cells that line blood vessels, known as endothelium. We will identify the specific molecules that regulate this build-up. We will also prove that our findings from cells hold true in mice, which are the typical animals used in studies of atherosclerosis. We will compare our findings using cells from men as well as women to determine if there is a sex-based difference. We are the only lab in Canada to study this process of transcytosis, by which the bad cholesterol (LDL) gets under endothelial cells. We therefore have the potential to make huge advances in this field of research.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
508974
Name
Lee Warren L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - C: Vascular System
Projecttitle
Deciphering the intracellular interactome of LDL during endothelial transcytosis - elucidating novel therapeutic targets for atherosclerosis
Programtype2
Operating Grants
Orgnameinp2
Unity Health Toronto
Cihramount2
$944,775
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Endothelium; Lipoprotein; Transcytosis
Abstract
Atherosclerosis leads to heart attacks and strokes and is a leading cause of death in Canada. The first step in the disease is the build-up of the bad cholesterol, LDL, in the wall of blood vessels. Specifically, LDL builds up under the innermost layer of arteries, called the endothelium. How the LDL gets under the endothelium is very poorly understood. We have discovered ways to study this process, which is known as LDL transcytosis. In earlier work, we discovered two molecules on the cell surface that bring LDL into the endothelial cell but almost nothing is known about what happens next. We now wish to understand the route taken by LDL as it traverses the cell. Does it interact with other parts of the cell? How does it move through the crowded cell? Understanding how LDL navigates across the endothelial cell will help us develop ways to prevent the development of heart disease. If we can prevent cholesterol from accumulating in the blood vessel wall, we will prevent heart disease and stroke. We will use sophisticated microscopes to study the process by which cholesterol builds up under the special cells that line blood vessels, known as endothelium. We will identify the specific molecules that regulate this build-up. We will also prove that our findings from cells hold true in mice, which are the typical animals used in studies of atherosclerosis. We will compare our findings using cells from men as well as women to determine if there is a sex-based difference. We are the only lab in Canada to study this process of transcytosis, by which the bad cholesterol (LDL) gets under endothelial cells. We therefore have the potential to make huge advances in this field of research.
Competitiondate
202409
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Lee, Warren L
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $944,775~ $0~
Unity Health Toronto - $944,775 Grant (2024-25) | Canada Spends